Reducing the burden of diabetic vascular complications

Mark E. Cooper, Michael Brownlee

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

The major burdens of diabetic vascular complications are debilitating morbidity and increased mortality. For people with both type 1 and type 2 diabetes, reduced quality of life and shortened lifespan are consequences of both the classical microvascular complications of retinopathy and nephropathy, and accelerated macrovascular disease. Fortunately, the outlook for these complications has improved over the last 20 years, with more precisely, timed laser photocoagulation for vision-threatening retinopathy, more rigorous management of blood pressure in those with or at risk of renal disease, including widespread use of agents which interrupt the renin-angiotensin system (RAS), and more intensive risk factor reduction, particularly liberal use of lipid lowering agents in this high-risk population for cardiovascular disease. With increasing elucidation of the underlying causes of diabetic complications (1) it is predicted that over the next two decades even better therapeutic strategies will be implemented to not only treat but also to retard and prevent the development of diabetic vascular complications.

Original languageEnglish
Title of host publicationDiabetes
Subtitle of host publicationTranslating Research into Practice
PublisherCRC Press
Pages159-172
Number of pages14
ISBN (Electronic)9781420047363
ISBN (Print)1420043714, 9781420043716
Publication statusPublished - 1 Jan 2008
Externally publishedYes

Cite this

Cooper, M. E., & Brownlee, M. (2008). Reducing the burden of diabetic vascular complications. In Diabetes: Translating Research into Practice (pp. 159-172). CRC Press.
Cooper, Mark E. ; Brownlee, Michael. / Reducing the burden of diabetic vascular complications. Diabetes: Translating Research into Practice. CRC Press, 2008. pp. 159-172
@inbook{1d6a638532a6411ca6ee416660ba3bd9,
title = "Reducing the burden of diabetic vascular complications",
abstract = "The major burdens of diabetic vascular complications are debilitating morbidity and increased mortality. For people with both type 1 and type 2 diabetes, reduced quality of life and shortened lifespan are consequences of both the classical microvascular complications of retinopathy and nephropathy, and accelerated macrovascular disease. Fortunately, the outlook for these complications has improved over the last 20 years, with more precisely, timed laser photocoagulation for vision-threatening retinopathy, more rigorous management of blood pressure in those with or at risk of renal disease, including widespread use of agents which interrupt the renin-angiotensin system (RAS), and more intensive risk factor reduction, particularly liberal use of lipid lowering agents in this high-risk population for cardiovascular disease. With increasing elucidation of the underlying causes of diabetic complications (1) it is predicted that over the next two decades even better therapeutic strategies will be implemented to not only treat but also to retard and prevent the development of diabetic vascular complications.",
author = "Cooper, {Mark E.} and Michael Brownlee",
year = "2008",
month = "1",
day = "1",
language = "English",
isbn = "1420043714",
pages = "159--172",
booktitle = "Diabetes",
publisher = "CRC Press",
address = "Australia",

}

Cooper, ME & Brownlee, M 2008, Reducing the burden of diabetic vascular complications. in Diabetes: Translating Research into Practice. CRC Press, pp. 159-172.

Reducing the burden of diabetic vascular complications. / Cooper, Mark E.; Brownlee, Michael.

Diabetes: Translating Research into Practice. CRC Press, 2008. p. 159-172.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Reducing the burden of diabetic vascular complications

AU - Cooper, Mark E.

AU - Brownlee, Michael

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The major burdens of diabetic vascular complications are debilitating morbidity and increased mortality. For people with both type 1 and type 2 diabetes, reduced quality of life and shortened lifespan are consequences of both the classical microvascular complications of retinopathy and nephropathy, and accelerated macrovascular disease. Fortunately, the outlook for these complications has improved over the last 20 years, with more precisely, timed laser photocoagulation for vision-threatening retinopathy, more rigorous management of blood pressure in those with or at risk of renal disease, including widespread use of agents which interrupt the renin-angiotensin system (RAS), and more intensive risk factor reduction, particularly liberal use of lipid lowering agents in this high-risk population for cardiovascular disease. With increasing elucidation of the underlying causes of diabetic complications (1) it is predicted that over the next two decades even better therapeutic strategies will be implemented to not only treat but also to retard and prevent the development of diabetic vascular complications.

AB - The major burdens of diabetic vascular complications are debilitating morbidity and increased mortality. For people with both type 1 and type 2 diabetes, reduced quality of life and shortened lifespan are consequences of both the classical microvascular complications of retinopathy and nephropathy, and accelerated macrovascular disease. Fortunately, the outlook for these complications has improved over the last 20 years, with more precisely, timed laser photocoagulation for vision-threatening retinopathy, more rigorous management of blood pressure in those with or at risk of renal disease, including widespread use of agents which interrupt the renin-angiotensin system (RAS), and more intensive risk factor reduction, particularly liberal use of lipid lowering agents in this high-risk population for cardiovascular disease. With increasing elucidation of the underlying causes of diabetic complications (1) it is predicted that over the next two decades even better therapeutic strategies will be implemented to not only treat but also to retard and prevent the development of diabetic vascular complications.

UR - http://www.scopus.com/inward/record.url?scp=84875594529&partnerID=8YFLogxK

M3 - Chapter (Book)

SN - 1420043714

SN - 9781420043716

SP - 159

EP - 172

BT - Diabetes

PB - CRC Press

ER -

Cooper ME, Brownlee M. Reducing the burden of diabetic vascular complications. In Diabetes: Translating Research into Practice. CRC Press. 2008. p. 159-172